Frovatriptan as a Transitional Therapy in Medication Overuse Headache

This study is currently recruiting participants.
Verified April 2013 by University of Calgary
Sponsor:
Collaborator:
AHS Cancer Control Alberta
Information provided by (Responsible Party):
Farnaz Amoozegar, University of Calgary
ClinicalTrials.gov Identifier:
NCT01044251
First received: January 5, 2010
Last updated: April 16, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: May 2014
  Estimated Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)